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African histoplasmosis caused by the fungus Histoplasma capsulatum var. duboisii is a rare endemic mycosis occuring 
in western and central regions of sub-Saharian Africa. For unknown reasons, although HIV infection and H. capsulatum 
var. duboisii coexist in Africa, this coinfection remains rare. In Europe, diagnosed cases of African histoplasmosis are all 
imported. 
We describe a case of African histoplasmosis on a Portuguese war veteran co-infected with HIV-2 who fought in Guiné-
Bissau in 1963-65 and Angola 1972. 
Objectives 
With banalization of business or leisure trips, endemic mycosis are becoming frequently diagnosed in countries outside their natural geographic endemic 
areas and only a high index of suspicion makes the diagnosis possible. Apart from trips, nowadays in Portugal 4% of the resident population is immigrant, 
mostly from Brasil (25.5%) but also from Angola and Guiné-Bissau (9.2%), being the former an endemic country of American histoplasmosis and the later of 
both American and African histoplasmosis.  
We consider histoplasmosis a probable underdiagnosed disease that should be suspected mainly in immunodeficient HIV positive individuals with a past 
history of travel or residence in an endemic area. 
Conclusion 
We report a case of a 76-year-old man, diagnosed with HIV-2 infection in the previous year (under combined 
antiretroviral therapy) presenting an ulcerated skin lesion on the right tight, just above the knee (Fig. 1) that proved to 
be caused by Histoplasma capsulatum var. duboisii. 
He was diagnosed pulmonary tuberculosis the year before and was finishing one year treatment. The solitary skin 
lesion begun as a small non-pruriginous eritematous papule, evolving in 6 month to a painless 3-4cm ulcer with raised 
borders surrounded by a hiperpigmented halo. There were no adenopathies or bone lesions. Respiratory samples and 
blood cultures were sistematically negative for Histoplasma capsulatum.  
He was initially treated with IV liposomal Amphotericin-B (4mg/Kg/d) for one month, followed by oral Itraconazol 
(400mg/d) with a favourable clinical outcome (complete resolution of skin lesion by day 20 of Itraconazol treatment). 
Methods 
Fig. 1 
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Histopathology of skin biopsy revealed a superficial ulceration with underlying granulomatous infiltrate with many giant cells, where numerous round 
mononucleated yeasts measuring 7-8 m, sometimes in chains, were evident and highlighted in Grocott stain (Fig. 2, 40x objective). 
Skin biopsy was observed on a wet mount with KOH and revealed numerous round yeasts  (Fig. 3, 40x objective) that were also seen on Gram stain (Fig 4: 
100x objective). 
Culture of skin biopsy on two Sabouraud dextrose agar (with and without cicloheximide) showed growth of a filamentous fungus compatible with Histoplasma 
capsulatum (Fig 5, Sabouraud dextrose culture medium), with large thick-walled spherical macroconidia with finger-like projections (tuberculate conidia) 
arising from short conidiophores, and small oval microconidia arising on short stalks from undifferentiated hyphae (Fig 6, Lactofenol blue, 40x objective). 
Reversion to the yeast fase has not been succeed yet. 
Identification was further confirmed by sequencing of genomic DNA fragments using the universal fungal primers ITS1 and ITS4. The sequences obtained were 
compared with sequences deposited in the GenBank and the result was: Histoplasma capsulatum var. duboisii (99% homology). The obtained consensus 
sequence was deposited in GenBank with the accession number KF228448. 
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